What is the current valuation of the halitosis treatment market in India as of 2024?

The halitosis treatment market in India was valued at $195.6 Million in 2024. Read More

What is the projected market valuation for the halitosis treatment market in India by 2035?

The market is projected to reach $600.0 Million by 2035. Read More

What is the expected CAGR for the halitosis treatment market in India during the forecast period 2025 - 2035?

The expected CAGR for the market during 2025 - 2035 is 10.73%. Read More

Which companies are the key players in the halitosis treatment market in India?

Key players include Procter & Gamble, Colgate-Palmolive, Unilever, Johnson & Johnson, GlaxoSmithKline, Church & Dwight, Henkel, and Listerine. Read More

What are the main segments of the halitosis treatment market in India?

The main segments include indication, diagnostic tests, and drug treatment. Read More

What was the valuation range for the gastrointestinal segment in the halitosis treatment market in 2024?

The gastrointestinal segment was valued between $25.0 Million and $75.0 Million in 2024. Read More

What diagnostic tests are included in the halitosis treatment market in India?

Diagnostic tests include Halimeter, Gas Chromatography, BANA Test, and Β-Galactosidase Activity Assay. Read More

What was the valuation range for antiseptics in the drug treatment segment in 2024?

Antiseptics were valued between $50.0 Million and $150.0 Million in 2024. Read More

How does the projected growth of the halitosis treatment market in India compare to its 2024 valuation?

The market is expected to grow significantly from $195.6 Million in 2024 to $600.0 Million by 2035. Read More

What are the potential future trends in the halitosis treatment market in India?

Future trends may include increased innovation in diagnostic tests and drug treatments, driven by the growing market demand. Read More

India Halitosis Treatment Market

India Halitosis Treatment Market Research Report By Indication (Respiratory, Liver, Kidney, Gastrointestinal, Systemic, Others), By Diagnostic Tests (Halimeter, Gas Chromatography, BANA Test, -Galactosidase Activity Assay, Others) and By Drug Treatment (Antacids, Antiseptics, Ranitidine, Others) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

10.73%

2024 Market Size

$ 195.6 Million

2035 Market Size

$ 600 Million

Healthcare ● Updated August 2026 Report ID: MRFR/HC/54795-HCR | Pages: 200 | Author: Satyendra Maurya, Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Indication (USD Million)
  1. 4.1.1 Respiratory
  2. 4.1.2 Liver
  3. 4.1.3 Kidney
  4. 4.1.4 Gastrointestinal
  5. 4.1.5 Systemic
  6. 4.1.6 Others
2. 4.2 Medical Device, BY Diagnostic Tests (USD Million)
  1. 4.2.1 Halimeter
  2. 4.2.2 Gas Chromatography
  3. 4.2.3 BANA Test
  4. 4.2.4 Β-Galactosidase Activity Assay
  5. 4.2.5 Others
3. 4.3 Medical Device, BY Drug Treatment (USD Million)
  1. 4.3.1 Antacids
  2. 4.3.2 Antiseptics
  3. 4.3.3 Ranitidine
  4. 4.3.4 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Procter & Gamble (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Colgate-Palmolive (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Unilever (GB)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Johnson & Johnson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 GlaxoSmithKline (GB)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Church & Dwight (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Henkel (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Listerine (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 INDIA MARKET ANALYSIS BY INDICATION
3. 6.3 INDIA MARKET ANALYSIS BY DIAGNOSTIC TESTS
4. 6.4 INDIA MARKET ANALYSIS BY DRUG TREATMENT
5. 6.5 KEY BUYING CRITERIA OF MEDICAL DEVICE
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF MEDICAL DEVICE
8. 6.8 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
9. 6.9 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
11. 6.11 MEDICAL DEVICE, BY INDICATION, 2024 (% SHARE)
12. 6.12 MEDICAL DEVICE, BY INDICATION, 2024 TO 2035 (USD Million)
13. 6.13 MEDICAL DEVICE, BY DIAGNOSTIC TESTS, 2024 (% SHARE)
14. 6.14 MEDICAL DEVICE, BY DIAGNOSTIC TESTS, 2024 TO 2035 (USD Million)
15. 6.15 MEDICAL DEVICE, BY DRUG TREATMENT, 2024 (% SHARE)
16. 6.16 MEDICAL DEVICE, BY DRUG TREATMENT, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY INDICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY DIAGNOSTIC TESTS, 2025-2035 (USD Million)
  3. 7.2.3 BY DRUG TREATMENT, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

India Halitosis Treatment Market Segmentation

India Halitosis Treatment Market By Indication (USD Million, 2025-2035)

Respiratory
Liver
Kidney
Gastrointestinal
Systemic
Others

India Halitosis Treatment Market By Diagnostic Tests (USD Million, 2025-2035)

Halimeter
Gas Chromatography
BANA Test
Β-Galactosidase Activity Assay
Others

India Halitosis Treatment Market By Drug Treatment (USD Million, 2025-2035)

Antacids
Antiseptics
Ranitidine
Others

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”